ImageneBio, Inc. - Common Stock, $0.001 par value (IMA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
IMA on Nasdaq
Shares outstanding
11,102,293
Price per share
$6.90
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
4,705,090
Total reported value
$38,346,527
% of total 13F portfolios
0%
Share change
+4,705,066
Value change
+$38,346,331
Number of holders
32
Price from insider filings
$6.90
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ImageneBio, Inc. - Common Stock, $0.001 par value (IMA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Deep Track Capital, LP 7.9% 878,516 Deep Track Capital, LP 28 Jul 2025
BIOTECHNOLOGY VALUE FUND L P 7.2% $6,416,816 802,102 BVF PARTNERS L P/IL 30 Sep 2025
Funicular Funds, LP 5.8% $4,211,322 643,933 Funicular Funds, LP 29 Dec 2025
Blue Owl Capital Holdings LP 4.8% $4,327,392 540,924 Blue Owl Capital Holdings LP 30 Sep 2025
Atlas Venture Fund X, L.P. 2.1% 241,800 Atlas Venture Fund X, L.P. 25 Jul 2025
BML Investment Partners, L.P. 1.9% 220,832 Leonard Braden Michael 25 Jul 2025

As of 30 Sep 2025, 32 institutional investors reported holding 4,705,090 shares of ImageneBio, Inc. - Common Stock, $0.001 par value (IMA). This represents 42% of the company’s total 11,102,293 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ImageneBio, Inc. - Common Stock, $0.001 par value (IMA) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Deep Track Capital, LP 7.9% 878,516 0.2% $7,159,905
BVF INC/IL 7.2% 802,102 0.26% $6,537,131
Blue Owl Capital Holdings LP 4.9% 540,924 1.4% $4,408,531
Omega Fund Management, LLC 4.1% 455,361 1.7% $3,711,192
ORBIMED ADVISORS LLC 3.4% 378,556 0.07% $3,085,231
Atlas Venture Life Science Advisors, LLC 3.4% 377,814 0.41% $3,079,184
RTW INVESTMENTS, LP 3% 334,445 0.03% $2,725,727
VANGUARD GROUP INC 2.1% 233,358 0% $1,901,868
BML Capital Management, LLC 1.6% 182,509 1.4% $1,487,448
CITADEL ADVISORS LLC 1.1% 122,247 0% $996,313
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.6% 66,666 0% $543,328
BlackRock, Inc. 0.47% 52,111 0% $424,704
NEA Management Company, LLC 0.45% 50,005 0.02% $407,541
GEODE CAPITAL MANAGEMENT, LLC 0.43% 47,688 0% $388,701
RENAISSANCE TECHNOLOGIES LLC 0.34% 37,378 0% $304,631
Sofinnova Investments, Inc. 0.29% 31,884 0.02% $259,855
Squarepoint Ops LLC 0.22% 24,170 0% $196,986
Aldebaran Capital, LLC 0.18% 19,562 0.15% $159,430
JACOBS LEVY EQUITY MANAGEMENT, INC 0.16% 17,708 0% $144,320
Rangeley Capital, LLC 0.14% 15,000 0.12% $122,250
NewEdge Advisors, LLC 0.12% 12,960 0% $105,623
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.12% 12,774 0% $104,108
UBS Group AG 0.04% 4,770 0% $38,875
BARCLAYS PLC 0.04% 3,987 0% $32,494
MORGAN STANLEY 0.01% 1,286 0% $10,481

Institutional Holders of ImageneBio, Inc. - Common Stock, $0.001 par value (IMA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 400 $2,760 +$2,760 $6.90 1
2025 Q3 4,705,090 $38,346,527 +$38,346,331 $8.15 32